Fasoracetam
Experimental racetam studied in ADHD; its effect in humans is not proven, and it is approved nowhere.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Pharmacology
Contents
DETAILED OVERVIEW
What is Fasoracetam?
Fasoracetam is an experimental racetam-type compound, originally developed in Japan. It is not approved as a medicine anywhere, and it has been studied for ADHD (attention-deficit hyperactivity disorder). It is banned in the United Kingdom, and elsewhere the legal status is uncertain when it is sold as a supplement.
It acts on certain receptors of glutamate, a brain messenger, increasing their number and activity. In ADHD studies in adolescents, early results looked promising, but the results of an expanded 2019 trial were mixed, so its effect in humans is not proven. Side effects can include headache, abdominal complaints and fatigue. It strengthens the effect of phenibut and of other substances acting on a similar calming system, and with longer use, strain on the liver and kidneys is a concern. It should be avoided in pregnancy and breastfeeding, because there are no safety data.
Mechanism
mGluR I/II/III up-regulation
Half-life
~5-8 h
Legal status
Investigational, clinical trials
Community accounts describe Fasoracetam as having an excellent profile and tolerability, with users commonly reporting significant anxiety reduction, improved focus and concentration, better sleep quality, and alleviation of ADHD-like symptoms. The net effect appears to depend on the degree of glutamatergic dysfunction, meaning it works best in individuals with signaling imbalances, most commonly seen in ADHD or neurodegenerative conditions. Fasoracetam normalizes GABA-B signaling and may aid in benzodiazepine withdrawal, with some community members combining occasional Phenibut alongside consistent Fasoracetam use to curb GABA-B downregulation. A choline source such as CDP-Choline is commonly recommended. Effects build over 1-2 weeks with chronic use as cAMP activity acts like a slow neuromodulator rather than producing acute effects. Highly individual but well-regarded for clean focus without stimulant-like activation.
⚠ Not clinical evidence – based on user accounts.
Receptor profile
- GABA-B receptorsStrong
- mGluR (Groups I, II, III)Moderate
- Choline uptakeModerate
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Headache, often from increased cholinergic activity (mitigated with a choline source such as CDP-choline)
- Abdominal pain, diarrhea and nausea, mainly at doses above the nootropic range
- Fatigue, lethargy
- Irritability
- Dizziness, mild lightheadedness, especially when starting use
Contraindications · 5
- Pregnancy and breastfeeding: no safety data, should be avoided
- Combined with phenibut or other GABA-B-active agents it potentiates their effect (GABA-B upregulation), caution required
- Prolonged high-dose use may burden liver and kidney function, caution with long-term use
- Clinical-trial-stage compound, not approved anywhere, long-term safety unknown
- Not recommended under 18; those on medication or with serious medical conditions should seek medical advice first
Related Nootropics
Same therapeutic category
FAQ
FAQ
Fasoracetam is a compound from the racetam family, originally developed in Japan, that acts on certain brain signaling systems (glutamate receptors). Its most concrete, documented use case is ADHD: it went through clinical trials (Phase 2/3) for that purpose. Based on the source, it's best understood as a research/clinical-stage compound rather than a widely established, everyday supplement.
Telegram
Have a question about Fasoracetam?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
